BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1624675)

  • 1. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
    Utsumi A; Hanew K; Sugawara A; Shimizu Y; Murakami O; Ikeda H; Yoshinaga K
    J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
    Colao A; Merola B; Ferone D; Calabrese MR; Longobardi S; Spaziante R; Di Renzo G; Annunziato L; Lombardi G
    Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
    Looij BJ; Nieuwenhuijzen Kruseman AC; Mudde AH; Frölich M; Piaditis GP; Hodgkinson SC; McLean C; Grossman A; Coy DH; Rees LH
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):149-56. PubMed ID: 2871949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Colasanti S; Barini A
    Metabolism; 1992 Sep; 41(9):949-53. PubMed ID: 1355581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to confirm a growth hormone-releasing activity of corticotropin-releasing hormone in acromegaly: comparison with the effects of other hypothalamic hormones.
    Watanobe H; Sasaki S; Takebe K
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):487-90. PubMed ID: 1759537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological role of galanin in the regulation of anterior pituitary function in humans.
    Giustina A; Licini M; Schettino M; Doga M; Pizzocolo G; Negro-Vilar A
    Am J Physiol; 1994 Jan; 266(1 Pt 1):E57-61. PubMed ID: 7508194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Watanobe H; Tamura T; Sasaki S; Takebe K
    Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly.
    Watanobe H; Tamura T
    Neuropeptides; 1995 Feb; 28(2):115-24. PubMed ID: 7746355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
    Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M
    J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of growth hormone-suppressing agents to affect TSH-releasing hormone- and LH-releasing hormone-induced growth hormone release in acromegaly.
    Nakagawa K; Obara T
    J Clin Endocrinol Metab; 1977 Jan; 44(1):189-93. PubMed ID: 401823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to thyrotropin-releasing hormone in liver cirrhosis: unique alteration in anterior pituitary responsiveness to hypothalamic hormones.
    Salerno F; Cocchi D; Lampertico M; Manneschi M; Monza G; Müller EE
    Horm Metab Res; 1982 Sep; 14(9):482-6. PubMed ID: 6128295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans.
    Arvat E; Gianotti L; Ramunni J; Grottoli S; Brossa PC; Bertagna A; Camanni F; Ghigo E
    Eur J Endocrinol; 1995 Sep; 133(3):300-4. PubMed ID: 7581945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of involvement of the cholinergic mechanism in vasoactive intestinal peptide- and peptide-histidine methionine-induced growth hormone (GH) responses in acromegaly: comparison with the GH responses to thyrotropin-releasing hormone and GH-releasing hormone.
    Watanobe H; Habu S; Nasushita R; Takebe K
    Neuropeptides; 1994 Aug; 27(2):85-90. PubMed ID: 7991070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of synthetic ovine corticotropin-releasing factor on growth hormone secretion in patients with acromegaly.
    Tanaka K; Watabe T; Yoshida H; Shimizu N
    Endocrinol Jpn; 1984 Jun; 31(3):355-61. PubMed ID: 6094167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior pituitary functions in patients with uremia tested by stimulation with four combined hypothalamic releasing hormones.
    Lee YJ; Tsai JH; Lai YH; Torng JK; Shin SJ; Wu CC
    Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1091-6. PubMed ID: 2561485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of GH responses to GHRH and somatostatin in patients with acromegaly.
    Hanew K; Sato S; Goh M; Sasaki A; Shimizu Y; Sugawara A; Ohtsuka T; Yoshinaga K
    Tohoku J Exp Med; 1988 Jul; 155(3):233-9. PubMed ID: 2902703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
    Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Liuzzi A; Chiodini PG
    J Clin Endocrinol Metab; 1986 Mar; 62(3):601-4. PubMed ID: 3080469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.